Direct Membrane Penetration of Oligoarginines by Fluorescence and Cryo-electron Microscopy Combined with Molecular Simulations

By integrating fluorescence microscopy, cryo-electron microscopy, and molecular simulations, this study reveals that arginine-rich peptides penetrate cells through a unified mechanism of membrane folding and multilamellar stacking, with observed morphological variations arising from the size of the available membrane reservoir.

The Gist

Imagine your cell is a fortress with a high, smooth wall (the cell membrane) protecting everything inside. Scientists have long been trying to figure out how to get tiny delivery trucks (drugs) over that wall without breaking it down. One of the most promising "delivery drivers" is a molecule called Arginine-rich peptide (specifically, a chain of nine arginines, or R9). It's like a super-charged, positively charged key that seems to magically slip through the wall.

But how does it actually get in? Does it punch a hole? Does it dissolve the wall? Or does it sneak in through a secret door?

This paper is like a high-tech detective story where the researchers used three different tools to solve the mystery: computer simulations (like a video game), fluorescence microscopes (glowing cameras), and Cryo-Electron Microscopy (a super-powerful 3D camera that freezes things in time).

Here is the story of what they found, explained simply:

1. The "Sticky" Key

First, the researchers tested different types of "keys." They found that a short key (4 arginines) or a key made of a different material (lysine) didn't work well. But the 9-arginine key (R9) was special.

• The Analogy: Think of the cell wall as having two sides. The outside is neutral, but the inside is negatively charged (like a magnet with a negative pole). The R9 key is positively charged (a positive magnet).
• The Result: The R9 key sticks very tightly to the wall, especially if the wall has certain "sticky" ingredients (like negative lipids). Once it sticks, it doesn't just sit there; it starts rearranging the bricks of the wall around it.

2. The Great Wall Remodeling (The "Fold and Stack" Trick)

This is the most exciting part. The researchers discovered that R9 doesn't just punch a hole. Instead, it acts like a folding machine.

• The Analogy: Imagine you have a piece of fabric (the cell membrane). If you put a heavy, sticky weight (the R9 peptide) on it, the fabric doesn't tear; it starts to bunch up, fold, and stack on top of itself.
• What they saw:
  • In simple test tubes (LUVs): The membrane started doing crazy acrobatics. It formed bubbles, split into two layers, and even stacked up like a sandwich with many layers of bread (multilamellarity).
  • In complex cells: The membrane folded and stacked so tightly that it created a "tunnel" or a "pocket" that eventually let the peptide slip inside.

3. Why the "Wall" Matters

The researchers found that the result depends on how much "extra fabric" (membrane) is available to fold.

• Small Vesicles (Tiny bubbles): If the bubble is small and tight, the R9 can only fold the wall a little bit, maybe making a double layer. It's like trying to fold a small handkerchief; you can only make a few folds.
• Big Cells: In a real, large cell, there is a huge reservoir of membrane. The R9 can fold and stack the wall over and over again, creating a massive, complex structure that eventually allows the peptide to cross over.

4. The "Puncta" (The Glowing Spots)

When they watched living cells under a microscope, they saw something cool. Before the peptide entered the cell, it gathered on the surface in bright, glowing dots (puncta).

• The Analogy: Imagine a crowd of people (the peptides) gathering at a gate. They don't just walk through; they pile up, creating a massive, folded structure right at the gate. Once the pile is high enough, they "spill over" into the cell.
• The Discovery: Using a special 3D camera (Cryo-ET), they looked at these glowing dots and saw they were actually deep, folded stacks of the cell membrane, looking like a crumpled piece of paper or a stack of pancakes.

The Big Conclusion: "Fold and Stack"

The paper proposes a single, unified theory for how these peptides work, which they call "Fold and Stack."

1. Stick: The peptide sticks to the membrane.
2. Fold: It pulls the membrane in, creating a curve or a bud.
3. Stack: It glues layers of the membrane together, creating a stack.
4. Cross: This stacking process eventually creates a pathway for the peptide to cross into the cell.

Why is this important?
For years, scientists argued about whether these peptides punched holes or melted the wall. This paper says, "No, they are master architects!" They don't break the wall; they remodel it. They fold the wall into a staircase that the peptide climbs up and over.

This discovery helps scientists design better drug delivery systems. Instead of trying to force a hole in the wall, we can design drugs that know how to "fold" the wall and sneak inside, delivering medicine right where it's needed without damaging the cell.

Technical Summary

1. Problem Statement

Cell-penetrating peptides (CPPs), particularly arginine-rich peptides like nonaarginine (R9), are widely used for drug delivery due to their ability to cross cellular membranes. However, the precise molecular mechanism of their entry remains controversial.

• The Debate: While some hypotheses suggest pore formation (similar to antimicrobial peptides), recent evidence points toward more complex membrane rearrangements.
• The Gap: There is a lack of unified understanding regarding how R9 interacts with membranes of varying complexity (from simple liposomes to live cells) and how these interactions translate into cellular entry. High levels of peptide-induced aggregation and fusion in experimental models have previously obscured the exact mode of action.

2. Methodology

The authors employed a multi-scale, correlative approach combining computational modeling, fluorescence spectroscopy, and advanced electron microscopy to study R9 interactions across systems of increasing complexity:

• Computational Modeling:
  • Molecular Dynamics (MD): Umbrella sampling simulations using Gromacs with CHARMM36 and charge-scaled ProsECCo75 force fields to calculate Potential of Mean Force (PMF) for peptide-membrane binding.
  • Continuum Elastic Modeling: Monte Carlo simulations and continuum models (Helfrich-Hamm-Kozlov formalism) to predict membrane curvature, invagination, and stability (stomatocyte formation) based on lipid composition and peptide binding energy.
• Fluorescence Spectroscopy:
  • Laurdan General Polarization (GP): Used to monitor changes in membrane lipid packing and phase transitions in Large Unilamellar Vesicles (LUVs) and Extracellular Vesicles (EVs) upon peptide addition.
• Microscopy & Imaging:
  • Live-Cell Confocal Microscopy: Used U-2 OS cells to visualize peptide entry, puncta formation, and nuclear translocation.
  • Flow Cytometry: Quantified peptide association and cell penetration efficiency at various concentrations.
  • Cryo-Electron Tomography (Cryo-ET): Performed on LUVs, cell-derived EVs, and live cells (frozen via plunge-freezing).
  • Correlative Light and Electron Microscopy (CLEM): Combined cryo-fluorescence microscopy with cryo-ET to locate specific fluorescent peptide puncta on cells and visualize their 3D ultrastructure.
  • Machine Learning: A two-stage Convolutional Neural Network (CNN) was trained to automatically classify membrane morphologies (unilamellar, bilamellar, multilamellar) and peptide presence in Cryo-ET tomograms.

3. Key Contributions

• Unified Mechanism: The study proposes a single, unified mechanism for R9 action ("Fold and Stack") that reconciles seemingly contradictory observations across different model systems.
• Role of Membrane Reservoir: It demonstrates that the observed membrane morphology is dictated not just by the peptide, but by the availability of the membrane reservoir.
  • Limited reservoir (single LUV/EV): Results in bilamellar bifurcations.
  • Abundant reservoir (cells/inter-vesicular): Results in extensive multilamellar stacking.
• Chemical Specificity: It establishes that the length of the peptide (9 vs. 4 residues) and the specific cationic side chain (Arginine vs. Lysine) are critical determinants of membrane remodeling efficiency.

4. Key Results

A. Computational Insights

• Binding Affinity: R9 binds significantly more strongly to anionic membranes (containing PS and PE) than K9 (nonalysine) or R4 (tetraarginine). The binding free energy for R9 on DDDC membranes is approx. -55 kJ/mol, roughly double that of K9.
• Curvature Induction: Simulations show R9 induces negative spontaneous curvature, driving lipid reorganization. This leads to the formation of invaginations (stomatocytes) and membrane folding.
• Peptide Specificity: R9 promotes lipid sorting (enrichment of PS/PE near the peptide) and membrane stacking more effectively than K9, which lacks the specific hydrogen-bonding capabilities of the guanidinium group.

B. Experimental Observations (LUVs and EVs)

• LUVs (Simple Models):
  • R9 induces extensive remodeling in PS/PE-rich membranes, causing budding, bifurcations, and the formation of multilamellar stacks (3+ bilayers).
  • K9 and R4 primarily cause inter-vesicular aggregation with minimal membrane remodeling.
  • Time-resolved Cryo-ET shows a progression from unilamellar to multilamellar structures over 10 minutes.
• EVs (Complex Models):
  • R9 induces remodeling but is largely confined to bilamellar bifurcations (two stacked bilayers).
  • The formation of complex multilamellar stacks is less frequent than in LUVs, likely due to the presence of proteins and glycans limiting membrane flexibility or reservoir availability.

C. Live Cell Imaging (CLEM)

• Puncta Formation: Upon addition to live cells, R9 forms distinct surface puncta (peptide-membrane complexes) that precede cytosolic entry.
• Ultrastructure: Correlative Cryo-ET reveals these puncta correspond to strongly folded, multilamellar membrane structures directly connected to the plasma membrane.
• Statistical Significance: Statistical analysis of 18 cells showed that R9-induced remodeling in live cells is almost exclusively multilamellar (47% of puncta), contrasting with the mixed morphologies seen in LUVs. This suggests that the complex cellular membrane environment and the availability of a large membrane reservoir drive the system toward extreme multilamellarity.

D. Cell Penetration Dynamics

• Efficiency: R9 penetrates U-2 OS cells with 98% efficiency, whereas K9 (10%) and R4 (~0%) are largely ineffective.
• Mechanism: Entry is preceded by the formation of surface puncta. The peptide aggregates on the surface, inducing massive membrane folding and stacking, which eventually leads to translocation into the cytosol and nucleus.
• Toxicity: High concentrations of R9 (>15 µM) cause cell bursting and death due to excessive membrane tension and depletion of the membrane reservoir.

5. Significance and Conclusion

This study resolves the debate on R9 entry mechanisms by demonstrating that membrane folding and stacking are the primary modes of action.

• The "Fold and Stack" Model: R9 binds to anionic lipids, inducing local curvature and lipid reorganization. This leads to membrane invagination (budding). Through peptide-mediated adhesion, these folded membranes stack upon each other.
• Context Dependence: The final morphology depends on the "membrane reservoir":
  • LUVs: Have excess membrane area relative to volume, allowing for complex multilamellar stacks.
  • EVs: Have limited reservoir, resulting in bilamellar structures.
  • Live Cells: Have a vast reservoir (plasma membrane + internal stores), allowing for the extensive multilamellar structures observed at entry sites.
• Implications: The findings suggest that successful drug delivery using arginine-rich peptides relies on the peptide's ability to induce specific lipid reorganization and membrane curvature, rather than simple pore formation. This insight is crucial for designing more efficient and less toxic CPP-based therapeutics.